Particle.news

Download on the App Store

First African Genome Study Identifies Two Genetic Variants Linked to Breast Cancer

Researchers in South Africa uncover novel genetic risk factors, highlighting the need for ancestry-specific tools and precision medicine.

Overview

  • The Sydney Brenner Institute for Molecular Bioscience conducted the first genome-wide association study (GWAS) of breast cancer in African women living on the continent.
  • Two genetic variants, RAB27A and USP22, were identified as being linked to breast cancer in black South African women, representing a significant advance in understanding breast cancer biology in African populations.
  • Existing polygenic risk scores, developed using European populations, were found to perform poorly in African contexts, underscoring the need for ancestry-specific risk prediction tools.
  • If further validated, RAB27A and USP22 could serve as targets for precision cancer therapies and biomarkers for identifying aggressive breast cancer cases.
  • The study emphasizes the underrepresentation of African populations in genomic research and calls for investment in African-centered genomics to address health disparities and improve disease outcomes.